IL2 and cancer: Our findings that excessive production of IL-2 by Tconvs in response to SA-4-1BBL costimulation is both necessary and sufficient in overcoming Treg suppression may have significant implications for treatment of diseases such as cancer, that are associated with an imbalance between Tconvs and Tregs.